Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

β-parvin Activators

β-parvin, a cytoskeletal protein, plays a crucial role in cell adhesion, migration, and signaling processes. As a component of the integrin-mediated focal adhesion complex, β-parvin acts as a scaffold protein, linking integrins to the actin cytoskeleton and various signaling molecules. This linkage is essential for transmitting mechanical signals from the extracellular matrix to the intracellular environment, regulating cell shape, motility, and differentiation. Moreover, β-parvin interacts with several cytoskeletal and signaling proteins, including paxillin, focal adhesion kinase (FAK), and ILK, thereby contributing to the dynamic regulation of focal adhesion turnover and cell adhesion dynamics.

The activation of β-parvin is tightly regulated by various mechanisms. One crucial mechanism involves its phosphorylation status, where phosphorylation at specific residues modulates its interaction with binding partners and its subcellular localization. For instance, phosphorylation by FAK and ILK enhances β-parvin's association with the focal adhesion complex, promoting its stability and function. Additionally, post-translational modifications such as ubiquitination and sumoylation have been implicated in regulating β-parvin activity and turnover. Furthermore, the availability of binding partners and the structural conformation of β-parvin also influence its activation state. For instance, the binding of integrins to extracellular matrix components triggers conformational changes in β-parvin, facilitating its interaction with other focal adhesion proteins and downstream signaling effectors. Overall, the activation of β-parvin is a tightly regulated process involving multiple signaling pathways and post-translational modifications, ensuring its precise control over cell adhesion and migration processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

Bisindolylmaleimide I (GF 109203X), a PKC inhibitor, indirectly enhances β-parvin activity by modulating the PKC pathway, which is involved in actin cytoskeleton reorganization where β-parvin plays a significant role.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632, free base, a ROCK inhibitor, indirectly activates β-parvin by affecting the RhoA/ROCK pathway, which influences actin dynamics and focal adhesion assembly, processes where β-parvin is involved.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin, an activator of adenylate cyclase, indirectly enhances β-parvin activity by increasing cAMP levels, which can modulate cytoskeletal organization and focal adhesion dynamics, implicating β-parvin's role.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$91.00
$267.00
13
(1)

ML-7 hydrochloride, a myosin light chain kinase inhibitor, indirectly activates β-parvin by altering actin-myosin contractility, thereby influencing the cytoskeletal rearrangements where β-parvin is active.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin, a SERCA pump inhibitor, indirectly enhances β-parvin activity by altering calcium signaling, which affects actin cytoskeleton dynamics and focal adhesion, key areas of β-parvin function.

(S)-(−)-Blebbistatin

856925-71-8sc-204253
sc-204253A
sc-204253B
sc-204253C
1 mg
5 mg
10 mg
25 mg
$72.00
$265.00
$495.00
$968.00
(2)

Blebbistatin, a myosin II inhibitor, indirectly activates β-parvin by modulating actomyosin contractility, impacting cytoskeletal organization and focal adhesion processes involving β-parvin.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$184.00
$305.00
59
(1)

Jasplakinolide, an actin stabilizer, indirectly activates β-parvin by stabilizing actin filaments, thus influencing the cytoskeletal architecture and focal adhesion assembly involving β-parvin.

CCG-1423

285986-88-1sc-205241
sc-205241A
1 mg
5 mg
$30.00
$90.00
8
(1)

CCG-1423, a RhoA transcriptional inhibitor, indirectly activates β-parvin by influencing RhoA-mediated signaling pathways, which play a role in actin dynamics and focal adhesion involving β-parvin.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002, a PI3K inhibitor, indirectly activates β-parvin by altering PI3K/Akt signaling, which is linked to actin cytoskeleton rearrangements and focal adhesion dynamics involving β-parvin.